Author

L. Arcaini

Institution: Policlinico San Matteo Fondazione

Observed institution: Policlinico San Matteo Fondazione

OpenAlex ID: A5077838065

P1115: a Multicenter Phase 1/2 Trial of Eo2463, a Microbial-derived Peptide Therapeutic Vaccine, as Monotherapy and in Combination With Lenalidomide and Rituximab, for Treatment of Patients With Indolent Nhl

2022 · P. L. Zinzani, S. M. Ansell, et al. · HemaSphere

Works count: 1

Citation count:

H-index:

I10-index: